The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Insulin resistance and cardiovascular disease
Open accessAbstract
Clearly, insulin resistance is not simply a problem of deficient glucose uptake in response to insulin, but a multifaceted syndrome that increases significantly the risk for cardiovascular disease. The links between insulin resistance and the associated dyslipidemia, hypertension, hypercoagulability, and atherosclerosis are numerous and complex. This complexity derives both from the almost certain multiple causes of the insulin resistance syndrome and from the interaction of genes predisposing to insulin resistance with other genes that have their own, independent impact on lipid metabolism, blood pressure regulation, coagulation, and artery wall biology. Nonetheless, I suggest that dysregulation of fatty acid metabolism plays a central role in the development of this phenotype. Thus, the association between insulin resistance and dyslipidemia is clearly initiated by increased FFA release from, or defective uptake of FFAs into, adipocytes. Recent studies linking fatty acids to endothelial dysfunction, together with the clear role of VLDL in the stimulation of PAI-1, further support the view that dysregulation of fatty acid metabolism sits close to the center of the pathophysiology of the insulin resistance syndrome, at least as it relates to risk for cardiovascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,006
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
Miller, G. J., & Miller, N. E. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92376-4 · Cited by 2,621
Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor
Acton, S., Rigotti, A., Landschulz, K. T., Xu, S., Hobbs, H. H., & Krieger, M. (1996) · Science · doi:10.1126/science.271.5248.518 · Cited by 2,026
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk
Austin, M. A., King, M. C., Vranizan, K. M., & Krauss, R. M. (1990) · Circulation · doi:10.1161/01.cir.82.2.495 · Cited by 1,411
Hamsten, A., Wiman, B., de Faire, U., & Blombäck, M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198512193132501 · Cited by 1,342
The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man.
DeFronzo, R. A., Cooke, C. R., Andres, R., Faloona, G. R., & Davis, P. J. (1975) · Journal of Clinical Investigation · doi:10.1172/jci107996 · Cited by 1,115
Laakso, M., Edelman, S. V., Brechtel, G., & Baron, A. D. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114644 · Cited by 930
Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
Bonora, E., Kiechl, S., Willeit, J., Oberhollenzer, F., Egger, G., Targher, G., Alberiche, M., Bonadonna, R. C., & Muggeo, M. (1998) · Diabetes · doi:10.2337/diabetes.47.10.1643 · Cited by 837
A Null Mutation in Murine CD36 Reveals an Important Role in Fatty Acid and Lipoprotein Metabolism
Febbraio, M., Abumrad, N. A., Hajjar, D. P., Sharma, K., Cheng, W., Pearce, S. F. A., & Silverstein, R. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19055 · Cited by 769
Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation
Steinberg, H. O., Tarshoby, M., Monestel, R., Hook, G., Cronin, J., Johnson, A., Bayazeed, B., & Baron, A. D. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119636 · Cited by 761
Aitman, T. J., Glazier, A. M., Wallace, C. A., Cooper, L. D., Norsworthy, P. J., Wahid, F. N., Al-Majali, K. M., Trembling, P. M., Mann, C. J., Shoulders, C. C., et al. (1999) · Nature Genetics · doi:10.1038/5013 · Cited by 735
Insulin Sensitivity and Atherosclerosis
Howard, G., O’Leary, D. H., Zaccaro, D., Haffner, S., Rewers, M., Hamman, R., Selby, J. V., Saad, M. F., Savage, P., & Bergman, R. (1996) · Circulation · doi:10.1161/01.cir.93.10.1809 · Cited by 729
Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice
Gavrilova, O., Marcus-Samuels, B., Graham, D., Kim, J. K., Shulman, G. I., Castle, A. L., Vinson, C., Eckhaus, M., & Reitman, M. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7901 · Cited by 676
Marx, N., Schönbeck, U., Lazar, M. A., Libby, P., & Plutzky, J. (1998) · Circulation Research · doi:10.1161/01.res.83.11.1097 · Cited by 587
Juhan-Vague, I., Alessi, M. C., & Vague, P. (1991) · Diabetologia · doi:10.1007/bf00403280 · Cited by 567
Role of Insulin in Endogenous Hypertriglyceridemia*
Reaven, G. M., Lerner, R. L., Stern, M. P., & Farquhar, J. W. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105666 · Cited by 511
Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia.
Law, R. E., Meehan, W. P., Xi, X. P., Graf, K., Wuthrich, D. A., Coats, W., Faxon, D., & Hsueh, W. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118991 · Cited by 476
Ibrahimi, A., Bonen, A., Blinn, W. D., Hajri, T., Li, X., Zhong, K., Cameron, R., & Abumrad, N. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.38.26761 · Cited by 370
Dixon, J., & Ginsberg, H. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40744-8 · Cited by 368
Self-citationRapp, J. H., Lespine, A., Hamilton, R. L., Colyvas, N., Chaumeton, A. H., Tweedie-Hardman, J., Kotite, L., Kunitake, S. T., Havel, R. J., & Kane, J. P. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.11.1767 · Cited by 340
Lewis, G. F., Uffelman, K. D., Szeto, L. W., & Steiner, G. (1993) · Diabetes · doi:10.2337/diab.42.6.833 · Cited by 324
SERUM-INSULIN IN ESSENTIAL HYPERTENSION AND IN PERIPHERAL VASCULAR DISEASE
Welborn, T. A., Breckenridge, A., Rubinstein, A. H., Dollery, C. T., & Fraser, T. R. (1966) · The Lancet · doi:10.1016/s0140-6736(66)92132-5 · Cited by 323
Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM.
Malmström, R., Packard, C. J., Caslake, M., Bedford, D., Stewart, P., Yki-Järvinen, H., Shepherd, J., & Taskinen, M.-R. (1997) · Diabetologia · doi:10.1007/s001250050700 · Cited by 319
Arai, T., Wang, N., Bezouevski, M., Welch, C., & Tall, A. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.2366 · Cited by 312
Fatty acid regulation of very low density lipoprotein production
Lewis, G. F. (1997) · Current Opinion in Lipidology · doi:10.1097/00041433-199706000-00004 · Cited by 294
Fisher, E. A., Zhou, M., Mitchell, D. M., Wu, X., Omura, S., Wang, H., Goldberg, A. L., & Ginsberg, H. N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20427 · Cited by 286
Self-citationAssociation of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis.
SNIDERMAN, A. D., WOLFSON, C., TENG, B., FRANKLIN, F. A., BACHORIK, P. S., & KWITEROVICH, P. O. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-6-833 · Cited by 266
PLASMA LIPID TRANSFER PROTEINS, HIGH-DENSITY LIPOPROTEINS, AND REVERSE CHOLESTEROL TRANSPORT
Bruce, C., Chouinard, R. A., & Tall, A. R. (1998) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.18.1.297 · Cited by 258
Horowitz, B. S., Goldberg, I. J., Merab, J., Vanni, T. M., Ramakrishnan, R., & Ginsberg, H. N. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116384 · Cited by 231
Self-citationDammerman, M., Sandkuijl, L. A., Halaas, J. L., Chung, W., & Breslow, J. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.10.4562 · Cited by 227
Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects.
Malmström, R., Packard, C. J., Caslake, M., Bedford, D., Stewart, P., Yki-Järvinen, H., Shepherd, J., & Taskinen, M. R. (1998) · Diabetes · doi:10.2337/diabetes.47.5.779 · Cited by 198
Eriksson, P., Nilsson, L., Karpe, F., & Hamsten, A. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.1.20 · Cited by 187
Nordestgaard, B. G., Tybjaerg-Hansen, A., & Lewis, B. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.1.6 · Cited by 159
Calles-Escandón, J., Mirza, S. A., Sobel, B. E., & Schneider, D. J. (1998) · Diabetes · doi:10.2337/diab.47.2.290 · Cited by 147
Familial combined hyperlipidemia and abnormal lipoprotein lipase.
Babirak, S. P., Brown, B. G., & Brunzell, J. D. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.10.1176 · Cited by 146
Ginsberg, H. N., Jones, J., Blaner, W. S., Thomas, A., Karmally, W., Fields, L., Blood, D. K., & Begg, M. D. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.11.1829 · Cited by 135
Self-citationAlbrink, M. J., Krauss, R. M., Lindgren, F. T., von der Groeben, J., Pan, S., & Wood, P. D. (1980) · Lipids · doi:10.1007/bf02534017 · Cited by 128
Murray, I., Havel, P. J., Sniderman, A. D., & Cianflone, K. (2000) · Endocrinology · doi:10.1210/endo.141.3.7364 · Cited by 109
Pravenec, M., Zídek, V., Šimáková, M., Křen, V., Krenová, D., Horký, K., Jáchymová, M., Míková, B., Kazdova, L., Aitman, T. J., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6691 · Cited by 106
A Docking Receptor for HDL Cholesterol Esters
Steinberg, D. H. (1996) · Science · doi:10.1126/science.271.5248.460 · Cited by 90
Klannemark, M., Orho, M., Langin, D., Laurell, H., Holm, C., Reynisdottir, S., Arner, P., & Groop, L. (1998) · Diabetologia · doi:10.1007/s001250051099 · Cited by 80
Absence of Cd36 mutation in the original spontaneously hypertensive rats with insulin resistance
Gotoda, T., Iizuka, Y., Kato, N., Osuga, J.-I., Bihoreau, M., Murakami, T., Yamori, Y., Shimano, H., Ishibashi, S., & Yamada, N. (1999) · Nature Genetics · doi:10.1038/10285 · Cited by 65
Li, X.-N., Grenett, H. E., Benza, R. L., Demissie, S., Brown, S. L., Tabengwa, E. M., Gianturco, S. H., Bradley, W. A., Fless, G. M., & Booyse, F. M. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.11.3215 · Cited by 56
Effect of exogenous hyperinsulinaemia on atherogenesis in cholesterol-fed rabbits
Nordestgaard, B. G., Agerholm-Larsen, B., & Stender, S. (1997) · Diabetologia · doi:10.1007/s001250050709 · Cited by 43
Wetsel, R. A., Kildsgaard, J., Zsigmond, E. M., Liao, W., & Chan, L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19429 · Cited by 40
Insulin Resistance and Hypertension
Landsberg, L. (1999) · Clinical and Experimental Hypertension · doi:10.3109/10641969909061017 · Cited by 36
[Insulin resistance and hypertension].
Acosta, J. H. (1995) · PubMed · Cited by 10
Cited by
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Pathophysiology of type 2 diabetes mellitus
Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176275 · Cited by 3,360
“This highly atherogenic lipid profile is a pivotal contributor to atherogenic dyslipidemia, which is causally linked to the development and progression of atherosclerotic CV disease (ASCVD) [233,234].”
BackgroundAssociation between insulin resistance and the development of cardiovascular disease
Ormazabal, V., Nair, S., Elfeky, O., Aguayo, C., Salomon, C., & Zuñiga, F. A. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0762-4 · Cited by 2,280
Cornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women
Bansal, S., Buring, J. E., Rifai, N., Mora, S., Sacks, F. M., & Ridker, P. M. (2007) · JAMA · doi:10.1001/jama.298.3.309 · Cited by 1,619
Metadata
- Authors
- Ginsberg, H. N.
- Venue
- Journal of Clinical Investigation
- Published
- 2000-08-15
- Volume
- 106
- Issue
- 4
- Pages
- 453-458
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2021976026
- Cited by
- 1,358
- References
- 53
- FWCI
- 41.95
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.